- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05736536
Behavior Intervention for Weight Loss for Type 2 Diabetes Mellitus Adults With Obesity Problem (BMI of ≥23kg/m2) (BMI)
Health Intervention on Behaviour Change to Act for Adults With Type 2 Diabetes Mellitus and Body Mass Index of ≥ 23kg/m2: a Quasi-Experimental Study
This quasi-experimental study aims to determine the effectiveness of a health intervention (Chance2Act) on behaviour change to act for weight loss among overweight/obese type 2 diabetes adults.
The main question it aims to answer is:
- Is the new health intervention (Chance2Act) effective in changing overweight/obese type 2 diabetes adults from not being ready to act, to take action to lose weight?
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pahang
-
Kuantan, Pahang, Malaysia, 25000
- Beserah Health Clinic
-
Kuantan, Pahang, Malaysia, 25000
- Paya Besar Health Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- T2DM patients under follow-up of government health clinics Kuantan, Pahang.
- Age between 20 - 65 years old.
- Body Mass Index of more or equal to 23 kg/m2.
- In the stage of pre-contemplation, contemplation, or preparation stage of change based on the S-weights questionnaire.
- Able to understand, read and write in the Malay Language.
- Have access to smartphone devices and internet services.
- Have immediate family members (adults) who are living in the same household.
Exclusion Criteria:
- Pregnant patients.
- Patients' advanced comorbidity that will affect participation in the study protocol (e.g. vision problem, unable to walk or physically unfit to stand up, advanced heart failure, or cancer).
- Patients with mental conditions which will affect understanding of the study protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
This group will receive a package of health education modules through Chance2Act website in addition to the existing health education being offered in the health clinic.
|
A Health education package that has been developed based on Transtheoretical Model to encourage behaviour change for weight loss among overweight/obese type 2 diabetes adults.
|
|
No Intervention: Control Group
This group will receive the existing health education being offered in the health clinic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes of readiness to change for weight loss (behaviour)
Time Frame: T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
The stage of change for weight loss is based on the S-weight questionnaire (Transtheoretical Model). Data type: Categorical data (either in pre-contemplation, contemplation, preparation, or action stage) |
T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes body mass index (anthropometric)
Time Frame: T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
The changes body mass index measurement
|
T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
|
Changes waist circumference (anthropometric)
Time Frame: T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
The changes waist circumference measurement
|
T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
|
Changes in body fat composition (anthropometric)
Time Frame: T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
The changes in body fat composition (total and visceral fat)
|
T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
|
Changes of self-efficacy for weight loss (behaviour)
Time Frame: T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
The changes for self-efficacy to control eating impulses based on Weight Efficacy Lifestyle Questionnaire (Transtheoretical Model). Domains (4 items in each domain)
Data type: Numerical data. A higher score shows better outcomes. Rating of each item: 0 - 9 Lowest score: 0 in each subscale Highest score: 36 in each subscale |
T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
|
Changes of decisional balance for weight loss (behaviour)
Time Frame: T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
The changes for decisional balance to decide on the pros and cons of weight loss based on the Decisional Questionnaire Inventory questionnaire (Transtheoretical Model). Domains (10 items in each domain)
Rating of each item: 1 - 5 Data type: Numerical data. Lowest score: 10 in each subscale Highest score: 50 in each subscale |
T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
|
Changes in family support for healthy diet and physical activity to encourage weight loss (social support)
Time Frame: T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
The changes for social support for weight loss based on the Social Support Scale for Diet and Exercise Domains:
Rating for each item: 1 - 5 Data type: Numerical data. Total subscale score: Family support for physical activity: 12 - 60: A higher score shows better outcomes. Family encouragement for healthy eating 5 - 25: A higher score shows better outcomes. Family discouragement for healthy eating 5 - 25: A higher score shows worse outcomes |
T0 (Week 0), T1 (Week 5), T2 (Week 9)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UiTMara Chance2Act
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
All data collected in the study will not be shared with other researchers to protect the confidentiality of patients' information as requested by the study site's authorized organization.
The study IPD includes:
- Study Protocol
- Statistical Analysis Plan
- Informed Consent Form
- Clinical Study Report
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.